The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b/2 study of nivolumab in combination with an anti–IL-8 monoclonal antibody, BMS-986253, in a biomarker-enriched population of patients with advanced cancer.
 
Ignacio Melero Bermejo
Honoraria - AstraZeneca; Lilly
Consulting or Advisory Role - Alligator Bioscience; AstraZeneca; Bayer; Bristol-Myers Squibb; Lilly; Roche; Tusk Therapeutics
Research Funding - Bristol-Myers Squibb; Pfizer; Tusk Therapeutics
Travel, Accommodations, Expenses - Roche
 
Elizabeth M. Jaffee
Consulting or Advisory Role - Aduro Biotech; Genocea Biosciences; Incyte; MedImmune
Research Funding - Aduro Biotech; Amgen; Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Aduro Biotech
 
Diwakar Davar
Consulting or Advisory Role - Incyte; Merck
Research Funding - Checkmate Pharmaceuticals; Incyte; Merck
 
Josephine Cardarelli
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Daphne Williams
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Penny Phillips
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb; Celgene
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
Other Relationship - Celgene (I)
 
Michael Carleton
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - BeiGene; Bristol-Myers Squibb; Five Prime Therapeutics; Incyte; Kite, a Gilead company; Nektar; Novartis; Tesaro
 
Ming Zhou
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Olivier De Henau
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Manish Monga
Employment - Bristol-Myers Squibb
 
Charles G. Drake
Stock and Other Ownership Interests - Compugen; ImmunExcite; NexImmune; Potenza Therapeutics; Tizona Therapeutics, Inc.
Consulting or Advisory Role - Agenus; Astellas Medivation; AstraZeneca/MedImmune; Bristol-Myers Squibb (Inst); Compugen; Dendreon; ImmuneXcite; Janssen Oncology; Lilly; Merck; NexImmune; Pfizer; Pierre Fabre; Potenza Therapeutics; Roche/Genentech; Tizona Therapeutics, Inc.
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); Compugen (Inst); Janssen Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Patents licensed to BMS (Inst); Patents licensed to Potenza Therapeutics (Inst)